Warfarin Dosing in Patients With Impaired Kidney Function
- 1 November 2010
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 56 (5) , 823-831
- https://doi.org/10.1053/j.ajkd.2010.05.023
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Public Health Consequences of Chronic Kidney DiseaseClinical Pharmacology & Therapeutics, 2009
- Defining Incident Chronic Kidney Disease in the Research Setting: The ARIC StudyAmerican Journal of Epidemiology, 2009
- Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002European Heart Journal, 2009
- Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the Centers for Disease Control and PreventionAmerican Journal of Kidney Diseases, 2009
- The effect of chronic renal failure on drug metabolism and transportExpert Opinion on Drug Metabolism & Toxicology, 2008
- Prevalence of chronic kidney disease in population-based studies: Systematic reviewBMC Public Health, 2008
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsBMJ, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Influence of CYP2C9 and VKORC1 1173C/T Genotype on the Risk of Hemorrhagic Complications in African-American and European-American Patients on WarfarinClinical Pharmacology & Therapeutics, 2007